Red X iconGreen tick iconYellow tick icon

Dr Rizwan is interested in novel formulation strategies for delivering pharmaceuticals to the brain. She and her lab are interested in two different routes; firstly via the intranasal route, and secondly across the blood-brain barrier.

Her research focus is investigating the formulation and physicochemical characterisation of lipid and polymer-based nano- and microparticle drug carriers. She is also trying to gain a better understanding of the biological basis of nanoparticle-mediated drug delivery across the healthy and diseased blood-brain barrier, and the biological basis of nose-to-brain drug delivery.

Find out more about Dr Rizwan's research

Publications

Banstola, A., Vautrelle, N., Bergin, D., Gray, J., Murray, E., Mohammad, Y., Rizwan, S., … Tan, E., & Reynolds, J. (2023, June). Translational feasibility of a novel focused ultrasound approach for phasic dopamine receptor stimulation in a sheep model of Parkinson’s disease. Poster session presented at the International Basal Ganglia Society (IBAGS) XIV Meeting, Stockholm, Sweden.

Prentice, R. N., & Rizwan, S. B. (2023). Translational considerations in the development of intranasal treatments for epilepsy. Pharmaceutics, 15(1), 233. doi: 10.3390/pharmaceutics15010233

Arora, S., Cooper, P., Friedlander, L., Rizwan, S., Seo, B., Rich, A., & Hussaini, H. (2022). Evaluation of IL-23 inhibitor as a pulp immunomodulating agent: An in vitro and in vivo study. New Zealand Dental Journal, 118(4), (pp. 167). [Abstract]

Sarker, A., Horsfield, J., & Rizwan, S. (2022, November). Lipid nanoparticles reduce immune cell infiltration in a zebrafish model of brain inflammation. Verbal presentation at the School of Pharmacy Research Day, Dunedin, New Zealand.

Sarker, A., Horsfield, J., & Rizwan, S. (2022, November). Ednogenous lipid nanoparticles reduce immune cell infiltration in a zebrafish model of neuroinflammation. Verbal presentation at the New Zealand Controlled Release Society (NZCRS) Symposium, Auckland, New Zealand.

Back to top